Author

Bárbara Meléndez

Hospital Virgen de la Salud - Cited by 2,389

Biography

Dr. Barbara Melendez is an Associate professor in the Department of Molecular Pathology Research Unit, Virgen de la Salud Hospital, Toledo, Spain. His study interests major on Molecular Pathology. In recent years, he has studied Brain tumors, Pathology. Currently, Dr. Melendez is the author/editors/reviewer in several international journals. He published 22 articles in many journals and the articles are informative and got good citations.
Title
Cited by
Year
Methods of measurement for tumor mutational burden in tumor tissue
B Meléndez, C Van Campenhout, S Rorive, M Remmelink, I Salmon, ...Translational lung cancer research 7 (6), 661, 2018201
192
2018
Tumor surface regularity at MR imaging predicts survival and response to surgery in patients with glioblastoma
J Pérez-Beteta, D Molina-García, JA Ortiz-Alhambra, ...Radiology 2 (1), 218-225, 2018201
88
2018
Impact on prognosis of the regional distribution of MGMT methylation with respect to the CpG island methylator phenotype and age in glioma patients
P Mur, ÁR De Lope, FJ Díaz-Crespo, T Hernández-Iglesias, T Ribalta, ...Journal of neuro-oncology 122 (3), 441-4, 2015201
50
2015
Epigenetic downregulation of TET3 reduces genome‐wide 5hmC levels and promotes glioblastoma tumorigenesis
A Carella, JR Tejedor, MG García, RG Urdinguio, GF Bayón, M Sierra, ...International journal of cancer 1 (2), 373-387, 2020202
46
2020
Tubastatin A, an inhibitor of HDAC6, enhances temozolomide‑induced apoptosis and reverses the malignant phenotype of glioblastoma cells
A Urdiciain, E Erausquin, B Meléndez, JA Rey, MA Idoate, JS CastresanaInternational journal of oncology 54 (5), 1797-1808, 2019201
36
2019
Molecular study of long-term survivors of glioblastoma by gene-targeted next-generation sequencing
D Cantero, Á Rodríguez de Lope, R Moreno De La Presa, JM Sepúlveda, ...Journal of Neuropathology & Experimental Neurology 77 (8), 710-716, 2018201
32
2018
Loss of 5hmC identifies a new type of aberrant DNA hypermethylation in glioma
AF Fernandez, GF Bayón, MI Sierra, RG Urdinguio, EG Toraño, ...Human molecular genetics 27 (17), 3046-3059, 2018201
28
2018
P144, a transforming growth factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines
G Gallo-Oller, A Vollmann-Zwerenz, B Meléndez, JA Rey, P Hau, J Dotor, ...Cancer letters 381 (1), 67-75, 2016201
26
2016
Clinical application of targeted next-generation sequencing for colorectal cancer patients: A multicentric Belgian experience
N D’Haene, Q Fontanges, N De Nève, O Blanchard, B Melendez, M Delos, ...Oncotarget 9 (29), 20761, 2018201
22
2018
TP53, ATRX alterations, and low tumor mutation load feature IDH-wildtype giant cell glioblastoma despite exceptional ultra-mutated tumors
D Cantero, M Mollejo, JM Sepúlveda, N D’Haene, MJ Gutiérrez-Guamán, ...Neuro-Oncology Advances 2 (1), vdz059, 2020202
22
2020
Genome‐wide methylation analysis in vestibular schwannomas shows putative mechanisms of gene expression modulation and global hypomethylation at the HOX gene cluster
M Torres‐Martín, L Lassaletta, JM de Campos, A Isla, GR Pinto, ...Genes, Chromosomes and Cancer 54 (4), 7-209, 2015201
19
2015
Epigenetic regulation of human hedgehog interacting protein in glioma cell lines and primary tumor samples
MH Shahi, I Zazpe, M Afzal, S Sinha, RB Rebhun, B Meléndez, JA Rey, ...Tumor Biology 36 (4), 2383-2391, 2015201
18
2015
Design and Validation of a Gene-Targeted, Next-Generation Sequencing Panel for Routine Diagnosis in Gliomas
N D’Haene, B Meléndez, O Blanchard, N De Nève, L Lebrun, ...Cancers 11 (6), 773, 2019201
17
2019
Morphological MRI-based features provide pretreatment survival prediction in glioblastoma
J Pérez-Beteta, D Molina-García, A Martínez-González, A Henares-Molina, ...European radiology 29 (4), 1968-1977, 2019201
16
2019
Clinical, radiological and molecular characterization of intramedullary astrocytomas
L Lebrun, B Meléndez, O Blanchard, N De Nève, C Van Campenhout, ...Acta neuropathologica communications 8 (1), 1-14, 2020202
16
2020
Whole exome sequencing in a case of sporadic multiple meningioma reveals shared NF2, FAM109B, and TPRXL mutations, together with unique SMARCB1 alterations in a subset of tumor …
M Torres-Martín, ME Kusak, A Isla, RR Burbano, GR Pinto, B Melendez, ...Cancer genetics 208 (6), 327-332, 202
15
2015
Morphologic Features on MR Imaging Classify Multifocal Glioblastomas in Different Prognostic Groups
J Pérez-Beteta, D Molina-García, M Villena, MJ Rodríguez, C Velásquez, ...American Journal of Neuroradiology 40 (4), 634-640, 2019201
14
2019
The synergistic effect of DZ‑NEP, panobinostat and temozolomide reduces clonogenicity and induces apoptosis in glioblastoma cells
J De La Rosa, A Urdiciain, I Zazpe, MV Zelaya, B Meléndez, JA Rey, ...International Journal of Oncology 56 (1), 283-300, 2020202
12
2020
Panobinostat potentiates temozolomide effects and reverses epithelial–mesenchymal transition in glioblastoma cells
A Urdiciain, B Meléndez, J Rey, M Idoate, J CastresanaEpigenomes 2 (1), 5, 20120
8
2018
Epigenetic Deregulation of the Histone Methyltransferase KMT5B Contributes to Malignant Transformation in Glioblastoma
V López, JR Tejedor, A Carella, MG García, P Santamarina-Ojeda, ...Frontiers in cell and developmental biology 9, 61838, 2021202
7
2021

Referred From: https://scholar.google.com/citations?hl=en&user=5BUcTR8AAAAJ

Cited by
Citations 2389
h-index 26
i10-index 48
Recommended Journals
Open Access Journals